Bicocca Open Archive

Logo unimib boa
CORDANI, NICOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.494
AS - Asia 3.558
EU - Europa 3.030
SA - Sud America 472
Continente sconosciuto - Info sul continente non disponibili 232
AF - Africa 68
OC - Oceania 8
Totale 12.862
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.243
IT - Italia 1.301
SG - Singapore 1.101
CN - Cina 763
VN - Vietnam 611
HK - Hong Kong 427
RU - Federazione Russa 361
BR - Brasile 347
DE - Germania 241
SE - Svezia 216
IE - Irlanda 199
CA - Canada 194
FR - Francia 149
IN - India 135
GB - Regno Unito 128
UA - Ucraina 101
KR - Corea 83
BD - Bangladesh 82
ID - Indonesia 69
FI - Finlandia 61
NL - Olanda 56
TR - Turchia 47
ES - Italia 45
JP - Giappone 43
AR - Argentina 42
PL - Polonia 40
IQ - Iraq 38
MX - Messico 32
CH - Svizzera 30
AT - Austria 27
PK - Pakistan 26
ZA - Sudafrica 25
SA - Arabia Saudita 21
VE - Venezuela 20
EC - Ecuador 19
CO - Colombia 17
PH - Filippine 17
UZ - Uzbekistan 15
DK - Danimarca 14
BE - Belgio 12
LT - Lituania 12
JO - Giordania 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
KE - Kenya 9
MA - Marocco 9
AL - Albania 8
AU - Australia 7
MY - Malesia 7
EG - Egitto 6
JM - Giamaica 6
NP - Nepal 6
PE - Perù 6
TH - Thailandia 6
BO - Bolivia 5
IR - Iran 5
KZ - Kazakistan 5
PS - Palestinian Territory 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
EU - Europa 4
GR - Grecia 4
LB - Libano 4
MT - Malta 4
OM - Oman 4
RO - Romania 4
AM - Armenia 3
CR - Costa Rica 3
MU - Mauritius 3
PY - Paraguay 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
BB - Barbados 2
BY - Bielorussia 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KH - Cambogia 1
LC - Santa Lucia 1
LY - Libia 1
Totale 12.622
Salva come PNG Salva come JPEG
Città #
Singapore 640
Ann Arbor 574
Ashburn 565
Milan 488
San Jose 423
Hong Kong 401
Dallas 264
Woodbridge 219
Chandler 203
Dublin 193
Hanoi 181
New York 177
Fairfield 168
Ho Chi Minh City 156
Houston 155
Hefei 150
Los Angeles 146
Frankfurt am Main 137
Toronto 113
Council Bluffs 110
Wilmington 109
Santa Clara 97
Beijing 96
Jacksonville 95
Chicago 86
Seattle 86
Seoul 78
Dearborn 69
The Dalles 69
Cambridge 62
Rome 60
Boardman 58
Jakarta 55
Buffalo 48
São Paulo 46
Columbus 44
Princeton 42
Shanghai 41
Lauterbourg 40
Moscow 38
Nanjing 37
Desio 35
Da Nang 33
Orem 33
Munich 30
Tokyo 30
London 28
Montreal 28
Phoenix 28
Lissone 27
Warsaw 25
Zurich 25
Helsinki 24
Brooklyn 23
Denver 21
Mumbai 20
Nuremberg 20
Poplar 20
Atlanta 19
Baghdad 19
Paris 19
Stockholm 19
Chennai 17
Haiphong 17
Lawrence 17
Kent 16
Monza 16
Seveso 16
Lachine 15
Pune 14
Rio de Janeiro 14
Vienna 14
Amsterdam 13
Ankara 12
Brussels 12
Carate Brianza 12
Genoa 12
Hải Dương 12
Johannesburg 12
Nanchang 12
North Charleston 12
Salt Lake City 12
Washington 12
Biên Hòa 11
Bắc Ninh 11
Ottawa 11
San Diego 11
Tashkent 11
Turin 11
Turku 11
Altamura 10
Can Tho 10
Cinisello Balsamo 10
Figino 10
Florence 10
Lappeenranta 10
Riyadh 10
Shenyang 10
Tianjin 10
Boston 9
Totale 7.810
Salva come PNG Salva come JPEG
Nome #
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 557
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 473
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 461
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 440
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 423
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 416
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 398
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 371
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 363
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues 361
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 360
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 349
Chronic myeloid leukemia: Second-line drugs of choice 336
Isolation of FAP Cells from Mouse Dystrophic Skeletal Muscle Using Fluorescence Activated Cell Sorting 336
Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma 333
Expression of heat shock protein 27 in human renal cell carcinoma 332
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 329
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 303
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 301
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 290
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 285
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer 276
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes 271
Comparative proteomics of membrane microdomains from renal cell carcinoma and adiacent normal kidney 268
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 258
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 246
Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts 237
Nitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro-Adipogenic Precursor Differentiation 229
Edaravone: A Novel Possible Drug for Cancer Treatment? 228
Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases 228
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 227
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 221
A Phase 2, Open Label, Multicenter, Single Arm Trial Evaluating the Activity and Safety of Abemaciclib + Aromatase Inhibitors (AIs) as Second-Line Treatment After First-Line Fulvestrant in Hormone-Receptor-Positive (HR+), Human-Epidermal-Growth-Factor-Receptor-Negative (HER2-) Metastatic Breast Cancer (MBC) Patients. Final Results of HERMIONE-7 Trial 219
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows 217
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study 215
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 207
Metronomic chemotherapy 191
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease 189
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons 188
The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFN alpha on pleomorphic sarcoma cells 187
Derangement of endothelial protein C receptor and thrombomodulin expression in the intestinal mucosa of patients with inflammatory bowel diseases 185
EGFR overexpression in malignant pleural mesothelioma: An immunohistochemical and molecular study with clinico-pathological correlations 171
Investigation of the origin of malignant fibrous histiocytoma and identification of specific predictive markers for this tumour 155
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 151
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models 71
Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations 10
Totale 12.862
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.687
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022263 0 42 48 32 8 21 13 15 11 19 21 33
2022/2023763 48 200 39 91 46 72 43 40 36 64 48 36
2023/2024906 50 50 32 51 115 187 146 40 53 39 41 102
2024/20252.210 121 181 147 120 191 88 140 56 224 321 188 433
2025/20266.085 652 498 528 709 669 284 905 242 407 490 278 423
2026/2027561 323 238 0 0 0 0 0 0 0 0 0 0
Totale 12.862